PUBLISHER: Grand View Research | PRODUCT CODE: 1888586
PUBLISHER: Grand View Research | PRODUCT CODE: 1888586
The global rigid endoscopes market size was estimated at USD 7.31 billion in 2024 and is projected to reach USD 11.11 billion by 2033, growing at a CAGR of 4.74% from 2025 to 2033. The increasing prevalence of cancer and cancer-related mortality globally is one of the factors expected to drive the market.
For instance, according to the Cancer Progress Report 2023 released by the American Cancer Society, in 2023, around 1,958,310 new cancer cases were diagnosed in the U.S., and 609,820 individuals succumbed to it. Projections indicate that by 2040, the number of new cancer cases could reach 2.3 million. As the prevalence of cancer rises globally, there is a growing need for effective diagnostic and treatment procedures. Endoscopes play a crucial role in offering minimally invasive options to accurately diagnose, stage, and treat various forms of cancer.
The increasing prevalence of cancer and cancer-related mortality globally is one of the factors expected to drive the market. For instance, according to the Cancer Progress Report 2023 released by the American Cancer Society, in 2023, around 1,958,310 new cancer cases were diagnosed in the U.S., and 609,820 individuals succumbed to it. Projections indicate that by 2040, the number of new cancer cases could reach 2.3 million. As the prevalence of cancer rises globally, there is a growing need for effective diagnostic and treatment procedures. Endoscopes play a crucial role in offering minimally invasive options to accurately diagnose, stage, and treat various forms of cancer.
Furthermore, endoscopic procedures, such as Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP), are valuable in detecting & assessing cancer in the gastrointestinal tract, lung, and other areas. These procedures allow for precise visualization of internal tissues, biopsy collection, and even removing precancerous growths or early-stage tumors without open surgery. This improves patient outcomes and significantly reduces recovery times & the risk of complications associated with invasive surgical procedures.
Minimally invasive or keyhole surgeries, utilizing small incisions for the diagnosis and treatment of various conditions, are gaining widespread acceptance globally. Surgeons are increasingly favoring robotic & endoscopic surgeries over conventional open surgeries due to the numerous benefits they offer.
Benefits of Minimally Invasive Surgeries
The rigid endoscopes market has witnessed a significant surge in FDA approvals and the launch of new products. This is due to the advancements in medical technology and an increasing demand for minimally invasive procedures. Moreover, innovations in imaging technology are facilitating the trend of new product launches, enhancing the precision & effectiveness of diagnostic and therapeutic procedures. The launch of new products is expanding the range of options available to healthcare providers, improving patient outcomes, and promoting competitive dynamics in the market. Hence, manufacturers are intensifying their R&D efforts to stay ahead in this rapidly evolving landscape.
These advancements highlight a significant shift in the market, with a growing number of FDA approvals and product launches improving patient safety and driving market growth. The growing number of healthcare centers, such as hospitals, oncology specialty clinics, and cancer centers, is increasing the need for rigid endoscopes, which is expected to drive market growth. The number of endoscopies being performed in hospitals is growing with the increase in hospital facilities. The number of hospitals is increasing in most countries, including the U.S., the UK, Italy, Spain, China, India, Brazil, South Africa, and the UAE. According to American Hospital Association, there are 6,120 hospitals in the U.S. in 2024. Similarly, in 2021, there were 1,300 hospitals in Canada. The European Union has around 15,000 hospitals. Moreover, the UK has 1148 hospitals as of August 2023.
In addition, recent technological advancements in endoscopy devices, such as visualization components and imaging enhancement, which enabled the detection of gastrointestinal lesions without requiring dye injection, have increased demand for these devices in hospitals, diagnostic centers, and clinics, thereby driving market growth. For instance, in September 2022, Olympus Corporation introduced VISERA ELITE III, a surgical visualization platform catering to the needs of surgeons and healthcare practitioners across various endoscopic disciplines. This platform offers multiple imaging modalities and enables minimally invasive procedures, such as laparoscopic cholecystectomy & laparoscopic colectomy. VISERA ELITE III is available in MEA, Europe, Oceania, Asia, and Japan.
Global Rigid Endoscopes Market Report Segmentation
This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global rigid endoscopes market report based on product, angle of view, product dimension, product length, surgical center size, surgical center location, end use, and region: